Wellington Management Group LLP 13D/13G Filings for Sangamo Therapeutics, Inc. (SGMO)

Wellington Management Group LLP 13D and 13G filings for Sangamo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-04
11:42 am
Sale
2020-12-31 13G Sangamo Therapeutics, Inc.
SGMO
Wellington Management Group LLP 229
0.000%
-7,840,453decrease
(-100.00%)
Filing